← Open Payments lookup

BENJAMIN KUNZE: Open Payments

NPI 1912301334 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$229 in 10 payments from 7 companies in 2025. Trend: 2023 $139 · 2024 $111 · 2025 $229

Food & beverage: $229
CompanyPaymentsAmount
Boston Scientific Corporation3$82
Astellas Pharma US Inc2$44
Legend Biotech USA Inc.1$23
Ethicon US, LLC1$22
Antares Pharma, Inc.1$21
PROGENICS PHARMACEUTICALS, INC.1$19
Myriad Genetic Laboratories, Inc.1$18

Products named: Cresemba, LithoVue, AMS 700, Tria Firm, CARVYKTI, Echelon; Endopath, XYOSTED, PYLARIFY.

Industry payments across TX — which companies pay providers there.